By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich said after the close of the market Tuesday that it has completed the acquisition of BioReliance Holdings for $350 million in cash.

It purchased the firm from Avista Capital Partners, which had acquired BioReliance nearly five years ago from Invitrogen, now part of Life Technologies, for $210 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.